Recent Company News

• 04:08 AM ET Nov 12, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (105 total)

• 04:06 AM ET Nov 11, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (86 total)

• 08:49 AM ET Nov 07, 2025
  

  Ipsen to present two late-breaking sessions at AASLD on new PBC data supporting IQIRVO's long-term efficacy, safety and mechanistic insights in fatigue (€122.90, -0.20)

• 07:33 AM ET Nov 07, 2025
  

  Rhythm Pharmaceuticals announces FDA extends review period by three months for IMCIVREE (setmelanotide) for patients with acquired hypothalamic obesity ($98.49, 0.00)

• 05:04 PM ET Oct 22, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:02 AM ET Oct 22, 2025
  

  Transcript Intelligence: Ipsen Q3 Sales and Revenue Guidance (€119.20, +6.10)

• 09:01 AM ET Oct 22, 2025
  

  Transcript Intelligence: Ipsen Q3 Sales and Revenue Themes (€119.20, +6.10)

• 09:01 AM ET Oct 22, 2025
  

  Transcript Intelligence: Ipsen Q3 Sales and Revenue Q&A (€119.20, +6.10)

• 08:45 AM ET Oct 22, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:34 AM ET Oct 22, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning